Latest News about Gilead Sciences Inc
Recent news which mentions Gilead Sciences Inc
Stocks making the biggest moves in the premarket: Peloton, Regeneron, Cardinal Health & more
February 05, 2021
From CNBC.com News
Biden to sign 10 executive orders to combat Covid pandemic; invoke Defense Production Act to make supplies
January 21, 2021
From CNBC.com News
Stocks making the biggest moves midday: Roku, Peloton, DraftKings, American Express and more
January 19, 2021
From CNBC.com News
Biden CDC pick confident there's enough Covid vaccine to meet target amid confusion over stockpile
January 17, 2021
From CNBC.com News
5 things to know before the stock market opens Friday
January 15, 2021
From CNBC.com News
U.S. potentially facing ‘perpetual infection’ of Covid in spring as new variants spread, warns Dr. Scott Gottlieb
January 14, 2021
From CNBC.com News
Biden unveils sweeping plan to combat the Covid pandemic in the U.S.
January 14, 2021
From CNBC.com News
Covid strain found in South Africa ‘could evade’ Eli Lilly's antibody drug, CEO warns
January 12, 2021
From CNBC.com News
Gilead CEO expects remdesivir to effectively treat Covid strains found in U.K., South Africa
January 11, 2021
From CNBC.com News
What to watch today: Dow set to drop after Friday record high
January 11, 2021
From CNBC.com News
5 things to know before the stock market opens Monday
January 11, 2021
From CNBC.com News
Stocks making the biggest moves in the premarket: Twitter, Gilead Sciences, Lululemon & more
January 11, 2021
From CNBC.com News
South African Covid variant appears to ‘obviate’ antibody drugs, Dr. Scott Gottlieb says
January 05, 2021
From CNBC.com News
Oxford researcher confident Covid vaccines can be adapted to protect against future virus strains
December 30, 2020
From CNBC.com News
‘I think this is already in the U.S.,’ Dr. Scott Gottlieb says of new U.K. Covid strain
December 21, 2020
From CNBC.com News
Dr. Scott Gottlieb says new UK Covid strain 'will not slip past our vaccines very easily'
December 21, 2020
From CNBC.com News
Dr. Scott Gottlieb expects Covid vaccine shortages to last even if Moderna receives clearance
December 18, 2020
From CNBC.com News
Stocks making the biggest moves in the premarket: Tilray, Aphria, Penumbra, Moderna & more
December 16, 2020
From CNBC.com News
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
December 14, 2020
From CNBC.com News
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Friday
November 20, 2020
From CNBC.com News
Stocks making the biggest moves in the premarket: Pfizer, Foot Locker, Hibbett Sports, Workday & more
November 20, 2020
From CNBC.com News
WHO tells doctors not to use Gilead's remdesivir as a coronavirus treatment, splitting with FDA
November 19, 2020
From CNBC.com News
Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
November 12, 2020
From CNBC.com News
Trump’s ex-FDA chief: 'Win or lose' the election, administration must do more to fight Covid
November 06, 2020
From CNBC.com News
Dr. Scott Gottlieb warns of a 'sustained period' in the U.S. of 1,000 Covid deaths per day
November 03, 2020
From CNBC.com News
U.S. reports record 99,321 new coronavirus cases as scientists warn latest surge just beginning
October 31, 2020
From CNBC.com News
U.S. only at 'the beginning of the steep part' of the coronavirus pandemic, Dr. Scott Gottlieb says
October 30, 2020
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.